SENATE BILL 583

51st legislature - STATE OF NEW MEXICO - first session, 2013

INTRODUCED BY

Richard C. Martinez

 

 

 

 

 

AN ACT

RELATING TO CONTROLLED SUBSTANCES; AMENDING AND ENACTING SECTIONS OF THE CONTROLLED SUBSTANCES ACT TO RECLASSIFY DIHYDROCODEINE AS A SCHEDULE II CONTROLLED SUBSTANCE IN CERTAIN COMBINATIONS; REQUIRING PATIENTS TO DISCLOSE CONCURRENT PRESCRIBED USE OF CONTROLLED SUBSTANCES WHEN SEEKING A PRESCRIPTION FOR A CONTROLLED SUBSTANCE; MANDATING TAMPER-RESISTANT PRESCRIPTIONS FOR CONTROLLED SUBSTANCES; PRESCRIBING PENALTIES.

 

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO:

     SECTION 1. Section 30-31-8 NMSA 1978 (being Laws 1972, Chapter 84, Section 8, as amended) is amended to read:

     "30-31-8. SCHEDULE III.--The following controlled substances are included in Schedule III:

          A. any material, compound, mixture or preparation containing limited quantities of any substance having a stimulant effect on the central nervous system [which] that is controlled and listed in Schedule II;

          B. unless listed in another schedule, any material, compound, mixture or preparation [which] that contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:

                (1) any substance [which] that contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances [which] that are specifically listed in another schedule;

                (2) chlorhexadol;

                (3) glutethimide;

                (4) lysergic acid;

                (5) lysergic acid amide;

                (6) methyprylon;

                (7) phencyclidine;

                (8) sulfondiethylmethane;

                (9) sulfonethylmethane; or

                (10) sulfonmethane;

          C. nalorphine;

          D. any material, compound, mixture or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof:

                (1) not more than one and eight-tenths grams of codeine, or any of its salts, per one hundred milliliters or not more than ninety milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;

                (2) not more than one and eight-tenths grams of codeine, or any of its salts, per one hundred milliliters or not more than ninety milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts;

                [(3) not more than three hundred milligrams of dihydrocodeinone, or any of its salts, per one hundred milliliters or not more than fifteen milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium;

                (4) not more than three hundred milligrams of dihydrocodeinone, or any of its salts, per one hundred milliliters or not more than fifteen milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts;

                (5) not more than one and eight-tenths grams of dihydrocodeine, or any of its salts, per one hundred milliliters or not more than ninety milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts;

                (6)] (3) not more than three hundred milligrams of ethylmorphine, or any of its salts, per one hundred milliliters or not more than fifteen milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized therapeutic amounts;

                [(7)] (4) not more than five hundred milligrams of opium per one hundred milliliters or per one hundred grams, or not more than twenty-five milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; or

                [(8)] (5) not more than fifty milligrams of morphine, or any of its salts, per one hundred milliliters or per one hundred grams with one or more active, non-narcotic ingredients in recognized therapeutic amounts;

          E. controlled substances added to Schedule III by rule adopted by the board pursuant to Section 30-31-3 NMSA 1978; and

          F. the board may exempt by regulation any compound, mixture or preparation containing any stimulant or depressant substance listed in Subsections A and B of this section from the application of any part of the Controlled Substances Act if the compound, mixture or preparation contains any active medicinal ingredients not having a stimulant or depressant effect on the central nervous system and if the admixtures are included in combinations, quantity, proportion or concentration that vitiate the potential for abuse of the substances [which] that have a stimulant or depressant effect on the central nervous system."

     SECTION 2. Section 30-31-23 NMSA 1978 (being Laws 1972, Chapter 84, Section 23, as amended) is amended to read:

     "30-31-23. CONTROLLED SUBSTANCES--POSSESSION PROHIBITED--REQUIRED DISCLOSURES.--

          A. It is unlawful for a person intentionally to:

                (1) possess a controlled substance unless the substance was obtained pursuant to a valid prescription or order of a practitioner while acting in the course of professional practice or except as otherwise authorized by the Controlled Substances Act; [It is unlawful for a person intentionally to]

                (2) possess a controlled substance analog; or

                (3) withhold information regarding concurrent prescribed use of a controlled substance when a patient is seeking a prescription for a controlled substance. Information related to the prescribing, administering and dispensing of controlled substances shall be reported to a state or other public health or law enforcement agency pursuant to rule or by request in a manner that conforms to state and federal privacy laws.

          B. A person who violates this section with respect to:

                (1) one ounce or less of marijuana or synthetic cannabinoids is, for the first offense, guilty of a petty misdemeanor and shall be punished by a fine of not less than fifty dollars ($50.00) or more than one hundred dollars ($100) and by imprisonment for not more than fifteen days, and, for the second and subsequent offenses, guilty of a misdemeanor and shall be punished by a fine of not less than one hundred dollars ($100) or more than one thousand dollars ($1,000) or by imprisonment for a definite term less than one year, or both;

                (2) more than one ounce and less than eight ounces of marijuana or synthetic cannabinoids is guilty of a misdemeanor and shall be punished by a fine of not less than one hundred dollars ($100) or more than one thousand dollars ($1,000) or by imprisonment for a definite term less than one year, or both; or

                (3) eight ounces or more of marijuana or synthetic cannabinoids is guilty of a fourth degree felony and shall be sentenced pursuant to the provisions of Section 31-18-15 NMSA 1978.

          C. A minor who violates this section with respect to the substances listed in this subsection is guilty of a petty misdemeanor and, notwithstanding the provisions of Sections 32A-1-5 and 32A-2-19 NMSA 1978, shall be punished by a fine not to exceed one hundred dollars ($100) or forty-eight hours of community service. For the third or subsequent violation by a minor of this section with respect to those substances, the provisions of Section 32A-2-19 NMSA 1978 shall govern punishment of the minor. As used in this subsection, "minor" means a person who is less than eighteen years of age. The provisions of this subsection apply to the following substances:

                (1) synthetic cannabinoids;

                (2) any of the substances listed in Paragraphs (20) through (25) of Subsection C of Section 30-31-6 NMSA 1978; or

                (3) a substance added to Schedule I by a rule of the board adopted on or after [the effective date of this] March 31, 2011 [act] if the board determines that the pharmacological effect of the substance, the risk to the public health by abuse of the substance and the potential of the substance to produce psychic or physiological dependence liability is similar to the substances described in Paragraph (1) or (2) of this subsection.

          D. Except for those substances listed in Subsection E of this section, a person who violates this section with respect to any amount of any controlled substance enumerated in Schedule I, II, III or IV or a controlled substance analog of a substance enumerated in Schedule I, II, III or IV is guilty of a misdemeanor and shall be punished by a fine of not less than five hundred dollars ($500) or more than one thousand dollars ($1,000) or by imprisonment for a definite term less than one year, or both.

          E. A person who violates this section with respect to phencyclidine as enumerated in Schedule III or a controlled substance analog of phencyclidine; methamphetamine, its salts, isomers or salts of isomers as enumerated in Schedule II or a controlled substance analog of methamphetamine, its salts, isomers or salts of isomers; flunitrazepam, its salts, isomers or salts of isomers as enumerated in Schedule I or a controlled substance analog of flunitrazepam, including naturally occurring metabolites, its salts, isomers or salts of isomers; gamma hydroxybutyric acid and any chemical compound that is metabolically converted to gamma hydroxybutyric acid, its salts, isomers or salts of isomers as enumerated in Schedule I or a controlled substance analog of gamma hydroxybutyric acid, its salts, isomers or salts of isomers; gamma butyrolactone and any chemical compound that is metabolically converted to gamma hydroxybutyric acid, its salts, isomers or salts of isomers as enumerated in Schedule I or a controlled substance analog of gamma butyrolactone, its salts, isomers or salts of isomers; 1-4 butane diol and any chemical compound that is metabolically converted to gamma hydroxybutyric acid, its salts, isomers or salts of isomers as enumerated in Schedule I or a controlled substance analog of 1-4 butane diol, its salts, isomers or salts of isomers; or a narcotic drug enumerated in Schedule I or II or a controlled substance analog of a narcotic drug enumerated in Schedule I or II is guilty of a fourth degree felony and shall be sentenced pursuant to the provisions of Section 31-18-15 NMSA 1978.

          F. Except for a minor as defined in Subsection C of this section, a person who violates Subsection A of this section while within a posted drug-free school zone, excluding private property residentially zoned or used primarily as a residence and excluding a person in or on a motor vehicle in transit through the posted drug-free school zone, with respect to:

                (1) one ounce or less of marijuana or synthetic cannabinoids is, for the first offense, guilty of a misdemeanor and shall be punished by a fine of not less than one hundred dollars ($100) or more than one thousand dollars ($1,000) or by imprisonment for a definite term less than one year, or both, and for the second or subsequent offense, is guilty of a fourth degree felony and shall be sentenced pursuant to the provisions of Section 31-18-15 NMSA 1978;

                (2) more than one ounce and less than eight ounces of marijuana or synthetic cannabinoids is guilty of a fourth degree felony and shall be sentenced pursuant to the provisions of Section 31-18-15 NMSA 1978;

                (3) eight ounces or more of marijuana or synthetic cannabinoids is guilty of a third degree felony and shall be sentenced pursuant to the provisions of Section 31-18-15 NMSA 1978;

                (4) any amount of any other controlled substance enumerated in Schedule I, II, III or IV or a controlled substance analog of a substance enumerated in Schedule I, II, III or IV, except phencyclidine as enumerated in Schedule III, a narcotic drug enumerated in Schedule I or II or a controlled substance analog of a narcotic drug enumerated in Schedule I or II, is guilty of a fourth degree felony and shall be sentenced pursuant to the provisions of Section 31-18-15 NMSA 1978; and

                (5) phencyclidine as enumerated in Schedule III, a narcotic drug enumerated in Schedule I or II, a controlled substance analog of phencyclidine or a controlled substance analog of a narcotic drug enumerated in Schedule I or II is guilty of a third degree felony and shall be sentenced pursuant to the provisions of Section 31-18-15 NMSA 1978.

          G. A person who violates the provisions of Paragraph (3) of Subsection A of this section is guilty of a fourth degree felony and shall be sentenced in accordance with the provisions of Section 31-18-15 NMSA 1978."

     SECTION 3. A new section of the Controlled Substances Act is enacted to read:

     "[NEW MATERIAL] CONTROLLED SUBSTANCES--TAMPER-RESISTANT PRESCRIBING.--

          A. A practitioner shall:

                (1) issue prescriptions for controlled substances exclusively through tamper-resistant prescription forms; and

                (2) employ reasonable safeguards to ensure against theft or unauthorized use of prescriptions for controlled substances.

          B. If a hard copy of a prescription for a controlled substance is given directly to a patient, the prescription shall be manually signed and provided on a tamper-resistant prescription form as defined in Subsection D of this section.

          C. By July 1, 2014, the board shall adopt and promulgate rules that set forth the features of tamper-resistant prescription forms that comply with the provisions of Subsection D of this section.

          D. For the purposes of this section, "tamper-resistant prescription form" means:

                (1) a pad or paper that has been approved for use in accordance with rules that the board has adopted and that has one or more industry-recognized features designed to prevent:

                     (a) unauthorized copying of a completed or blank prescription form;

                     (b) the erasure or modification of information written on the prescription form by the practitioner; and

                     (c) the use of counterfeit prescription forms; or

                (2) an electronic medium that meets industry-recognized standards for being tamper-resistant and for preventing unauthorized access to the electronic prescription."

- 12 -